Aerosol Formulation For The Inhalation Of Beta Agonists

Patent No. EP1940349 (titled "Aerosol Formulation For The Inhalation Of Beta Agonists") was filed by Boehringer Ingelheim on Oct 6, 2006. The application was issued on Feb 14, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSNov 13, 2018ELKINGTON AND FIFE
TEVA PHARMACEUTICALSNov 13, 2018ELKINGTON & FIFE
TEVA UKNov 13, 2018ELKINGTON & FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1940349

BOEHRINGER INGELHEIM
Application Number
EP06807028A
Filing Date
Oct 6, 2006
Status
Opposition Rejected
Jul 10, 2020
Publication Date
Feb 14, 2018